Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alleviating Carbohydrate-Counting Burden in Type 1 Diabetes Using Artificial Pancreas and Sodium Glucose-Linked Transporter 2 Inhibition: A Randomized Open-Label Crossover Trial.

NCT03510000 is registered in ClinicalTrials.gov with Samuel Lunenfeld Research Institute, Mount Sinai Hospital as lead sponsor.

NCT NCT03510000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03510000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alleviating Carbohydrate-Counting Burden in Type 1 Diabetes Using Artificial Pancreas and Sodium Glucose-Linked Transporter 2 Inhibition: A Randomized Open-Label Crossover Trial.
Lead sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 15, 2018
Completion date
November 21, 2019
Enrollment
30 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

type1diabetes